Intervention Review

Oral theophylline for chronic obstructive pulmonary disease

  1. Felix SF Ram1,
  2. Paul Jones2,
  3. Jose Jardim3,
  4. Aldemar A Castro4,
  5. Álvaro N Atallah5,
  6. Yves Lacasse6,
  7. Roger Goldstein7,
  8. Sonia Cendon3

Editorial Group: Cochrane Airways Group

Published Online: 21 OCT 2002

Assessed as up-to-date: 17 APR 2002

DOI: 10.1002/14651858.CD003902


How to Cite

Ram FSF, Jones P, Jardim J, Castro AA, Atallah ÁN, Lacasse Y, Goldstein R, Cendon S. Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003902. DOI: 10.1002/14651858.CD003902.

Author Information

  1. 1

    Massey University - Auckland, School of Health Sciences, Auckland, New Zealand

  2. 2

    St George's Hospital Medical School, Cardiovascular Medicine, London, UK

  3. 3

    Escola Paulista de Medicina, Universidade Federal de São Paulo, Disciplina de Pneumologia, São Paulo, São Paulo, Brazil

  4. 4

    State University of Heath Science, Department of Public Health, Maceió, Alagoas, Brazil

  5. 5

    Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  6. 6

    Institut Universitaire de Cardiologie et de Pneumologie de Québec, Hôpital Laval, Québec, Quebec, Canada

  7. 7

    West Park Healthcare Centre, University of Toronto, Division of Respiratory Medicine, Toronto, Ontario, Canada

*Toby J Lasserson, Cochrane Editorial Unit, The Cochrane Collaboration, 11-13 Cavendish Square, London, W1G 0AN, UK. tlasserson@cochrane.org.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 OCT 2002

SEARCH